Records containing: Idiopathic Inflammatory Myopathies
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27An Open-label, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 Following Single-ascending Dose and Step-up Dose Administration to Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-04-24Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders
-
CLINICAL_TRIALS study record update · 2026-04-16Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders
-
CLINICAL_TRIALS study record update · 2026-04-16Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders
-
CLINICAL_TRIALS study record update · 2026-04-16A Study on the Safety, Tolerability and Efficacy of MTS109 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases, an Investigator-Initiated Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase 1/2 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With Immune-Mediated Diseases
-
CLINICAL_TRIALS study record update · 2026-03-19A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) Anti-CD20 CAR-engineered Allogeneic Gamma-Delta (γδ) T Cells in Adults With Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2026-03-17An Open-label, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 Following Single-ascending Dose and Step-up Dose Administration to Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-03-06Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-02-18CARTIMMUNE: A Single-Center Study of Patients With Autoimmune Diseases Receiving an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (KYV 101)
-
CLINICAL_TRIALS study record update · 2026-02-17Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
-
CLINICAL_TRIALS study record update · 2026-02-11A Phase 1b, Open-label, Multi-cohort Study of AZD0120, an Autologous CD19/BCMA Targeting Chimeric Antigen Receptor T-cell, in Adults With Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-02-05A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Refractory Idiopathic Inflammatory Myopathies (IIM)
-
CLINICAL_TRIALS study record update · 2026-02-03Clinical Study on the Safety, Efficacy, and Pharmacokinetics of CAR-T Cell Injection Targeting CD19 in the Treatment of Patients With Active Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-01-21Tongji NADs Cohort: A Real-world Observation of Neurological Autoimmune Disorders
-
CLINICAL_TRIALS study record update · 2026-01-16Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
-
CLINICAL_TRIALS study record update · 2026-01-08The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants With Refractory B Cell-mediated Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-12-16A Phase 1, First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of XmAb657 in Healthy Participants and in Participants With Idiopathic Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2025-12-03Efficacy, Immunogenicity and Safety of Recombinant Vaccine Against Herpes Zoster (RZV or SHINGRIX®) in Patients With Autoimmune Rheumatic Diseases
-
CLINICAL_TRIALS study record update · 2025-07-22EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
-
CLINICAL_TRIALS study record update · 2025-06-15Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-05-22Clinical Study on the Safety, Efficacy, and Pharmacokinetics of a Universal CD19-Targeted CAR-T Cell Injection (RD06-04) in the Treatment of Patients With Refractory Inflammatory Myopathy and ANCA-Associated Vasculitis
-
CLINICAL_TRIALS study record update · 2025-05-14A Single-Arm, Open-Label, Single-Center Investigator-Initiated Early-Stage Clinical Study for Relapsed/Refractory (R/R) Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-04-10Investigating the Role of Hematopoietic Mutations and Mosaic Mutation in the Y Chromosome in Autoimmune Rheumatologic Diseases
-
CLINICAL_TRIALS study record update · 2025-02-11PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS